Comparison of alteplase (tissue plasminogen activator) high-dose vs. low-dose protocol in restoring hemodialysis catheter function: the ALTE-DOSE study.

Yaseen, Obead; El-Masri, Maher M; El Nekidy, Wasim S; Soong, Derrick; Ibrahim, Mohammed; Speirs, John W; Kadri, Albert

Yaseen, Obead; El-Masri, Maher M; El Nekidy, Wasim S; Soong, Derrick; Ibrahim, Mohammed; Speirs, John W; Kadri, Albert.

Affiliation

Yaseen O; Department of Nephrology, Hotel-Dieu Grace Hospital, Windsor, Ontario, Canada.

Hemodial Int ; 17(3): 434-40, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23176161

Subject(s)

Catheters, Indwelling; Kidney Failure, Chronic/therapy; Renal Dialysis/methods; Tissue Plasminogen Activator/administration & dosage; Aged; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Kidney Failure, Chronic/drug therapy; Male; Middle Aged; Prognosis; Renal Dialysis/instrumentation; Retrospective Studies; Survival Analysis; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Catheters, Indwelling / Renal Dialysis / Tissue Plasminogen Activator / Kidney Failure, Chronic Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Hemodial Int Journal subject: NEFROLOGIA / TERAPEUTICA Year: 2013 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google